Our study elaborated a novel circGFRA-miR-188-3p-PI3K/AKT regulatory pathway, providing a potential diagnostic biomarker and therapeutic target for NSCLC.
circGFRA1 Enhances NSCLC Progression by Sponging miR-188-3p.